2023-06-01 2024-05-31 false Capium Accounts Production 1.1 13417898 2023-06-01 2024-05-31 13417898 bus:AbridgedAccounts 2023-06-01 2024-05-31 13417898 bus:Micro-entities 2023-06-01 2024-05-31 13417898 bus:AuditExempt-NoAccountantsReport 2023-06-01 2024-05-31 13417898 bus:SmallCompaniesRegimeForAccounts 2023-06-01 2024-05-31 13417898 bus:PrivateLimitedCompanyLtd 2023-06-01 2024-05-31 13417898 2023-06-01 2024-05-31 13417898 2024-05-31 13417898 bus:RegisteredOffice 2023-06-01 2024-05-31 13417898 core:WithinOneYear 2024-05-31 13417898 core:AfterOneYear 2024-05-31 13417898 1 2023-06-01 2024-05-31 13417898 bus:Director1 2023-06-01 2024-05-31 13417898 bus:Director1 2024-05-31 13417898 bus:Director1 2022-06-01 2023-05-31 13417898 2022-06-01 13417898 bus:LeadAgentIfApplicable 2023-06-01 2024-05-31 13417898 2022-06-01 2023-05-31 13417898 2023-05-31 13417898 core:WithinOneYear 2023-05-31 13417898 core:AfterOneYear 2023-05-31 13417898 bus:EntityAccountantsOrAuditors 2022-06-01 2023-05-31 13417898 core:CostValuation core:Non-currentFinancialInstruments 2024-05-31 13417898 core:CostValuation core:Non-currentFinancialInstruments 2023-05-31 13417898 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2024-05-31 13417898 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 13417898 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2024-05-31 13417898 core:Non-currentFinancialInstruments 2024-05-31 13417898 core:Non-currentFinancialInstruments 2023-05-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 13417898
England and Wales

 

 

 

CLINIQON LTD


Abridged Accounts
 


Period of accounts

Start date: 01 June 2023

End date: 31 May 2024
  2024   2023
    £ £   £ £
Current assets 8,522      6,252   
Creditors: amount falling due within one year (5,780)     (4,426)  
Net current assets   2,742      1,826 
Total assets less current liabilities   2,742      1,826 
Net assets   2,742      1,826 
 

         
Capital and reserves   2,742      1,826 
 
NOTES TO THE ACCOUNTS

General Information
CLINIQON LTD is a private company, limited by shares, registered in England and Wales, registration number 13417898, registration address 20-22 WENLOCK ROAD, LONDON , N1 7GU.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
Statement of compliance
These financial statements have been prepared in compliance with FRS 105 – The Financial Reporting Standard applicable in the UK and Republic of Ireland and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention as modified by the revaluation of land and buildings and certain financial instruments measured at fair value in accordance with the accounting policies.
The financial statements are prepared in sterling which is the functional currency of the company.
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Tangible fixed assets
Tangible fixed assets, other than freehold land, are stated at cost or valuation less depreciation and any provision for impairment. Depreciation is provided at rates calculated to write off the cost or valuation of fixed assets, less their estimated residual value, over their expected useful lives on the following basis:
2.

Average number of employees

Average number of employees during the year was 2 (2023 : 2).


For the year ended 31 May 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's Responsibilities:
The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.

The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These accounts have been prepared in accordance with the micro-entity provisions and FRS 105, the Financial Reporting Standard applicable to the micro-entities regime. The accounts have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. The income statement has not been delivered to the Registrar of Companies.

The members have agreed to the preparation of abridged accounts.
The financial statements were approved by the director on 08 July 2024 and were signed by:


--------------------------------
Braimoh Umoru
Director
1